Health systems around the world were recently brought into the spotlight due to COVID-19. The pandemic showed the strengths and weaknesses of different health systems and demonstrated the importance of efficient health systems in promoting and maintaining the health of a population. The long-term impact of the global outbreak remains to be seen, but it is clear the pandemic revealed flaws in health systems. Changes to funding, organization, and institutions may end up being a positive result of a terrible event.
FCL Industry Coverage
- Devices & Supplies
- Technology Systems
- Pharmaceutical & Biotechnology
Deal activity in the first three quarters of 2021 was 9% lower than the same period last year with 15,978 closed transactions. Q3 volume slightly dropped from 4,445 to 4,878 deals as the backlog caused by the pandemic starts to normalize. Venture Capital buyers were the most active class of investors representing 62.2% of the total deals closed.